Frontier IP Group Plc (FIPP.L) Announced that portfolio company Exscientia ("Exscientia" or the "Company"), a world leader in artificial intelligence ("AI") drug discovery, has entered into a drug discovery collaboration with Rallybio. Rallybio is a US-based drug development company aiming to transform the lives of patients with rare diseases.
Login or register to post comments